Skip to main content
. 2023 Apr 13;12(5):1283–1297. doi: 10.1007/s40121-023-00801-5
Tmarneffei infection in humans remains neglected owing to the lack of competent knowledge of disease performance and prognosis.
We systematically analyzed the clinical characteristics, prognostic factors, and survival outcomes of 241 patients infected with Tmarneffei and compared the differences between individuals who were HIV positive and HIV negative.
Clinical features of Tmarneffei differ in patients who are HIV positive and HIV negative.
Patients who are HIV negative with Tmarneffei infection have a higher neutrophil count, more organ damage, and present a higher mortality.